JP2013508412A5 - - Google Patents

Download PDF

Info

Publication number
JP2013508412A5
JP2013508412A5 JP2012535428A JP2012535428A JP2013508412A5 JP 2013508412 A5 JP2013508412 A5 JP 2013508412A5 JP 2012535428 A JP2012535428 A JP 2012535428A JP 2012535428 A JP2012535428 A JP 2012535428A JP 2013508412 A5 JP2013508412 A5 JP 2013508412A5
Authority
JP
Japan
Prior art keywords
optionally substituted
substituted
compound
heteroaryl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012535428A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013508412A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/053825 external-priority patent/WO2011050305A1/en
Publication of JP2013508412A publication Critical patent/JP2013508412A/ja
Publication of JP2013508412A5 publication Critical patent/JP2013508412A5/ja
Pending legal-status Critical Current

Links

JP2012535428A 2009-10-22 2010-10-22 mGluR4アロステリック増強剤、組成物、および神経機能不全を治療する方法 Pending JP2013508412A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25406209P 2009-10-22 2009-10-22
US61/254,062 2009-10-22
US29272510P 2010-01-06 2010-01-06
US61/292,725 2010-01-06
PCT/US2010/053825 WO2011050305A1 (en) 2009-10-22 2010-10-22 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction

Publications (2)

Publication Number Publication Date
JP2013508412A JP2013508412A (ja) 2013-03-07
JP2013508412A5 true JP2013508412A5 (https=) 2013-12-05

Family

ID=43900711

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012535428A Pending JP2013508412A (ja) 2009-10-22 2010-10-22 mGluR4アロステリック増強剤、組成物、および神経機能不全を治療する方法
JP2012535430A Withdrawn JP2013508413A (ja) 2009-10-22 2010-10-22 mGluR4アロステリック増強剤、組成物、および神経機能不全を治療する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012535430A Withdrawn JP2013508413A (ja) 2009-10-22 2010-10-22 mGluR4アロステリック増強剤、組成物、および神経機能不全を治療する方法

Country Status (12)

Country Link
US (2) US9180192B2 (https=)
EP (2) EP2490537A4 (https=)
JP (2) JP2013508412A (https=)
KR (2) KR20120129869A (https=)
CN (2) CN102665417A (https=)
AU (2) AU2010310518A1 (https=)
BR (2) BR112012009576A2 (https=)
CA (2) CA2779298A1 (https=)
IL (2) IL219296A0 (https=)
MX (2) MX2012004774A (https=)
RU (2) RU2012121630A (https=)
WO (2) WO2011050316A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG173465A1 (en) 2009-01-28 2011-09-29 Univ Vanderbilt Substituted 1,1,3,3-tetraoxidobenzo[d][1,3,2]dithiazoles as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
US8759377B2 (en) 2009-11-23 2014-06-24 Vanderbilt University Substituted dioxopiperidines and dioxopyrrolidines as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
JP6161537B2 (ja) 2010-04-07 2017-07-12 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト ピラゾール−4−イル−ヘテロシクリル−カルボキサミド化合物及び使用の方法
AR088061A1 (es) 2011-09-27 2014-05-07 Hoffmann La Roche Compuestos de pirazol-4-il-heterociclil-carboxamida y metodos de uso
EP2853532B1 (en) 2013-09-28 2020-12-09 Instytut Farmakologii Polskiej Akademii Nauk 1,2,4-oxadiazole derivatives as allosteric modulators of metabotropic glutamate receptors belonging to group III
US10221172B2 (en) 2015-01-13 2019-03-05 Vanderbilt University Benzothiazole and benzisothiazole-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
US10227343B2 (en) 2015-01-30 2019-03-12 Vanderbilt University Isoquiniline and napthalene-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
US10526323B2 (en) 2015-01-30 2020-01-07 Vanderbilt University Indazole and azaindazole substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
WO2016179351A1 (en) 2015-05-05 2016-11-10 Northwestern University Treatment of levodopa-induced dyskinesias
WO2016202935A1 (en) 2015-06-19 2016-12-22 Bayer Pharma Aktiengesellschaft Glucose transport inhibitors
US10710997B2 (en) 2016-09-01 2020-07-14 Vanderbilt University Isoquinoline amide and isoquinoline amide-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
US10294222B2 (en) 2016-09-01 2019-05-21 Vanderbilt University Benzomorpholine and benzomorpholine-substituted compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
US10968227B2 (en) 2016-11-08 2021-04-06 Vanderbilt University Isoquinoline ether compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
US11242342B2 (en) 2016-11-08 2022-02-08 Vanderbilt University Isoquinoline amine compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
US11319304B2 (en) 2017-06-28 2022-05-03 Vanderbilt University Pyridine quinoline compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
IL272575B2 (en) * 2017-08-16 2023-09-01 Univ Vanderbilt Indazole compounds as allosteric enhancers of mglur4, compositions and methods for treating neurological dysfunction
US20220089609A1 (en) 2018-07-26 2022-03-24 Domain Therapeutics Substituted quinazolinone derivatives and their use as positive allosteric modulators of mglur4
WO2020113094A1 (en) 2018-11-30 2020-06-04 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
TW202043198A (zh) * 2019-01-17 2020-12-01 美商Ifm Due有限公司 用於治療與sting活性相關之病況的化合物及組合物
CN121108187A (zh) 2019-04-03 2025-12-12 阿里戈斯治疗公司 吡咯化合物
UY39892A (es) 2021-08-10 2023-03-31 Novartis Pharma Ag Compuestos y composiciones para tratar afecciones asociadas con la actividad de STING

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660753B2 (en) * 1999-08-19 2003-12-09 Nps Pharmaceuticals, Inc. Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
WO2005007096A2 (en) * 2003-07-11 2005-01-27 Merck & Co., Inc. Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator
WO2005030128A2 (en) * 2003-09-23 2005-04-07 Merck & Co., Inc. Pyrazole modulators of metabotropic glutamate receptors
US7414060B2 (en) * 2005-03-04 2008-08-19 Hoffmann-La Roche Inc. Pyridine-2-carboxyamide derivatives
US8324265B2 (en) * 2005-11-21 2012-12-04 Shionogi & Co., Ltd. Heterocyclic compounds having type I 11β hydroxysteroid dehydrogenase inhibitory activity
US8110530B2 (en) 2006-12-21 2012-02-07 Kumiai Chemical Industry Co., Ltd. Herbicidal composition
JP5361857B2 (ja) 2007-03-23 2013-12-04 ファイザー・リミテッド イオンチャネルの阻害剤
TWI443090B (zh) * 2007-05-25 2014-07-01 Abbvie Deutschland 作為代謝性麩胺酸受體2(mglu2 受體)之正向調節劑之雜環化合物
GB0713686D0 (en) 2007-07-13 2007-08-22 Addex Pharmaceuticals Sa New compounds 2

Similar Documents

Publication Publication Date Title
JP2013508412A5 (https=)
JP2013508413A5 (https=)
JP2013510178A5 (https=)
RU2013103792A (ru) Новое производное никотинамида или его соль
JP2010529147A5 (https=)
JP2007520471A5 (https=)
JP2010504286A5 (https=)
JP2009263394A5 (https=)
ES2572148T3 (es) Un método para el tratamiento de la enfermedad de Pompe usando 1-desoxinojirimicina y derivados
NO20091451L (no) Bicykliske heteroaromatiske forbindelser
PE20141372A1 (es) Nuevos derivados dihidroquinolina-2-ona
WO2008051533A3 (en) Benzimidazole compounds
AR083542A1 (es) Piperidin-4-il-azetidin diamidas como inhibidores de monoacilglicerol lipasa
WO2008111441A1 (ja) 医薬組成物
JP2013509392A5 (https=)
MXPA04005350A (es) Compuesto de dibencilamina, y uso medicinal del mismo.
JP2006521359A5 (https=)
WO2008010048A3 (en) Novel 2-substituted methyl penam derivatives
PE20090290A1 (es) Derivados de pirrolopiridina como inhibidores de bace
CO6160231A2 (es) Compuestos de isoindolina 5-substituidos
JP2014517808A5 (https=)
AR059622A1 (es) Quinolonas utiles como inhibidores de la sintetasa del oxido nitrico inducibles
AR057894A1 (es) Derivados de tiofeno
PE20130155A1 (es) Derivados de ariletinilo
JP2015042636A5 (ja) 有機化合物